These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23871412)

  • 21. Is inflammatory bowel disease more severe when it appears at younger ages?
    Rogler G
    Digestion; 2010; 81(4):235-6. PubMed ID: 20110708
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetics of adalimumab in inflammatory bowel diseases: a systematic review and meta-analysis.
    Paul S; Moreau AC; Del Tedesco E; Rinaudo M; Phelip JM; Genin C; Peyrin-Biroulet L; Roblin X
    Inflamm Bowel Dis; 2014 Jul; 20(7):1288-95. PubMed ID: 24831559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Standard immunosuppression in IBD: current practice.
    Feagan BG
    Acta Gastroenterol Belg; 2001; 64(2):182-8. PubMed ID: 11475131
    [No Abstract]   [Full Text] [Related]  

  • 24. Aspects of human disease.
    Scully C; Chaudhry SI
    Dent Update; 2007 Jun; 34(5):317. PubMed ID: 17624150
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: a case study of five patients with treatment-resistant inflammatory bowel disease.
    Egan LJ; Tremaine WJ; Mays DC; Lipsky JJ; Sandborn WJ
    Inflamm Bowel Dis; 2000 Nov; 6(4):286-9. PubMed ID: 11149561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of chronic inflammatory bowel disease based on evidence and according to stage: step up].
    Rogler G
    Dtsch Med Wochenschr; 2013 Sep; 138(36):1778. PubMed ID: 24002878
    [No Abstract]   [Full Text] [Related]  

  • 27. [Inflammatory bowel disease: an overview].
    Herrlinger K
    Med Monatsschr Pharm; 2013 Nov; 36(11):402-8; quiz 409. PubMed ID: 24640117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory Bowel Disease and Clostridium difficile-associated diarrhea: a growing problem.
    Tremaine WJ
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):310-1. PubMed ID: 17368229
    [No Abstract]   [Full Text] [Related]  

  • 29. Inflammatory bowel disease.
    Podolsky DK
    N Engl J Med; 2002 Aug; 347(6):417-29. PubMed ID: 12167685
    [No Abstract]   [Full Text] [Related]  

  • 30. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine.
    Korelitz BI; Mirsky FJ; Fleisher MR; Warman JI; Wisch N; Gleim GW
    Am J Gastroenterol; 1999 Nov; 94(11):3248-53. PubMed ID: 10566724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing disease activity and disease activity indices for inflammatory bowel disease.
    Xiao Li F; Sutherland LR
    Curr Gastroenterol Rep; 2002 Dec; 4(6):490-6. PubMed ID: 12441039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Methotrexate in therapy of gastrointestinal diseases].
    Schröder O; Stein J
    Z Gastroenterol; 1999 Jul; 37(7):623-37. PubMed ID: 10458012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting the need for azathioprine at first presentation in children with inflammatory bowel disease.
    Mossop H; Davies P; Murphy MS
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):123-9. PubMed ID: 18664861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunosuppression in inflammatory bowel disease: When, how and how long?].
    Gross V
    Dtsch Med Wochenschr; 2012 Sep; 137(37):1803-5. PubMed ID: 22956222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring 6-thioguanine nucleotide concentrations in Japanese children and adolescents with inflammatory bowel disease.
    Ohtsuka Y; Arai K; Aoyagi Y; Fujii T; Yamakawa Y; Ohtani K; Ikuse T; Baba Y; Inage E; Kudo T; Suzuki R; Nagata S; Shimizu T
    J Gastroenterol Hepatol; 2010 Oct; 25(10):1626-30. PubMed ID: 20880170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy and safety of cyclosporine in the treatment of inflammatory bowel disease in children - a retrospective study].
    Socha P; Wawer Z; Ryzko J; Orłowska E; Szczepański M; Kierkus J; Celińska-Cedro D; Socha J
    Med Wieku Rozwoj; 2006; 10(2):429-35. PubMed ID: 16825713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methotrexate: should we start using it in clinical practice?
    Miheller P; Kiss LS; Mandel M; Lakatos PL
    Curr Drug Targets; 2013 Nov; 14(12):1480-9. PubMed ID: 23651163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of oral corticosteroids in inflammatory bowel diseases in Italy: An IG-IBD survey.
    Fascì-Spurio F; Meucci G; Papi C; Saibeni S;
    Dig Liver Dis; 2017 Oct; 49(10):1092-1097. PubMed ID: 28801181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive factors of glucocorticosteroid treatment failure in severe acute idiopathic colitis.
    Elloumi H; Ben Abdelaziz A; Derbel F; Jmaa A; Lassoued Y; Arfaoui D; Ben Ali A; Letaief R; Hamida RB; Ghannem H; Ajmi S
    Acta Gastroenterol Belg; 2005; 68(2):226-9. PubMed ID: 16013638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methotrexate for Inflammatory Bowel Diseases - New Developments.
    Herfarth HH
    Dig Dis; 2016; 34(1-2):140-6. PubMed ID: 26981630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.